Some, including Zydus Lifesciences, have announced "Day 1" launches, suggesting generic versions may become available as soon as this weekend in India
The Rebate Trap: How High List Prices Became Structurally Necessary To understand why pharmaceutical manufacturers have been slow to lower list prices even when Cubans model demonstrated it was commercially viable, you need to understand the rebate game and why it creates a perverse incentive for high prices to persist
Retrieved from McKenzie, Y
Some medical professionals prescribe L-carnitine in supplement form to help support those with heart conditions, diabetes, erectile dysfunction, and other health conditions
GIP (glucose-dependent insulinotropic polypeptide) receptor activation enhances fat metabolism and appears to reduce the GI side effects that come from GLP-1 stimulation alone
However, recent advances in peptide therapies, stem cell treatments, and NAD+ supplementation are showing potential